Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region.
about
Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidateAllele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route.Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans.Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirusMechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites.Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.A comparative study of the genetic diversity of the 42kDa fragment of the merozoite surface protein 1 in Plasmodium falciparum and P. vivax.The immunological challenge to developing a vaccine to the blood stages of malaria parasites.Impact of pre-existing MSP1(42)-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine.Effective induction of high-titer antibodies by viral vector vaccines.The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment.Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malariaA chimeric Plasmodium falciparum merozoite surface protein vaccine induces high titers of parasite growth inhibitory antibodiesProtection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4.Humoral immune responses to a recombinant Plasmodium vivax tryptophan-rich antigen among Plasmodium vivax-infected patients and its localization in the parasite.Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection.Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys.
P2860
Q28748331-A013BC12-B6D3-4BF6-8FD3-54DAC1EB02A5Q33653151-FB768C49-DBA4-48F9-A675-862567591276Q33742070-5DA099E0-827B-4C29-A490-B428335D66A6Q34072792-6D6F8447-29FC-4724-AD68-557B549F9583Q34081745-8BE0CF3D-1A79-4F2C-A9D0-3584D52A6630Q34334187-1D32E5CB-A343-418B-ADB1-8A0E4EFA53F0Q34726966-C3BE754C-1840-4C05-A467-A5E45251C4F6Q35177864-9435F1B4-A19B-4899-9F85-3F5A9FC3AF46Q35606514-A78FD532-D4E0-4447-A00B-EFE679B987F4Q35623459-6A3F8C05-C05C-4316-A231-8B7695839F9AQ35754172-632748B9-5F2E-42ED-89D4-52A39AB3E7E9Q35884247-BB0B9C47-CFB9-4729-8E52-A75FBA9E93A9Q36412687-5BA605F9-2EED-4170-966C-DDEAA6CDB3F7Q36770379-031A2767-34E7-4D5C-9EF6-63F3DF07FBDCQ36785777-FA42DF8F-D895-4368-A41F-7CF9E1AFEB37Q37146236-2EAFF1DD-9526-4ADD-9394-17F14FFA04C9Q37264673-4F96B71E-5C01-4947-BDC6-9D1B90379804Q37523881-409A587F-57CB-4EBD-A4CC-9528CC7C7D24Q37523989-2453B70D-62C9-4134-9B07-62F677701889Q40047869-EE0BF067-0690-470C-BA6B-65F254B1655FQ41622508-F8826CAD-FA22-4443-A2B8-50010D1B36D4Q42415030-7E1AB10B-8664-415F-9CDE-99ACDD349F2DQ43013555-38AD3EF1-231C-43A2-87D8-B47C300E2439
P2860
Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Protective immune responses to ...... by the adjacent 33-kDa region
@nl
Protective immune responses to ...... by the adjacent 33-kDa region.
@ast
Protective immune responses to ...... by the adjacent 33-kDa region.
@en
type
label
Protective immune responses to ...... by the adjacent 33-kDa region
@nl
Protective immune responses to ...... by the adjacent 33-kDa region.
@ast
Protective immune responses to ...... by the adjacent 33-kDa region.
@en
prefLabel
Protective immune responses to ...... by the adjacent 33-kDa region
@nl
Protective immune responses to ...... by the adjacent 33-kDa region.
@ast
Protective immune responses to ...... by the adjacent 33-kDa region.
@en
P2093
P2860
P921
P1476
Protective immune responses to ...... by the adjacent 33-kDa region.
@en
P2093
Irene T Ling
Niklas Ahlborg
Wendy Howard
P2860
P304
P356
10.1128/IAI.70.2.820-825.2002
P407
P577
2002-02-01T00:00:00Z